Human immune cell targeting of protein nanoparticles – caveospheres

Enhancing dendritic cell activation and HIV vaccine effectiveness through nanoparticle vaccination

(2016) Joshua J. Glass et al.   Expert Review of Vaccines

Monoclonal Antibody-Functionalized Multilayered Particles: Targeting Cancer Cells in the Presence of Protein Coronas

(2015) Qiong Dai et al.   ACS Nano

Engineering Poly(ethylene glycol) Particles for Improved Biodistribution

(2015) Jiwei Cui et al.   ACS Nano

Synthetic Nanoparticles for Vaccines and Immunotherapy

(2015) Darrell J. Irvine et al.   CHEMICAL REVIEWS

Molecular Characterization of Caveolin-induced Membrane Curvature

(2015) Nicholas Ariotti et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Targeting Ability of Affibody-Functionalized Particles Is Enhanced by Albumin but Inhibited by Serum Coronas

(2015) Qiong Dai et al.   ACS Macro Letters

Diagnostic nanoparticle targeting of the EGF-receptor in complex biological conditions using single-domain antibodies

(2014) K. Zarschler et al.   Nanoscale

CALGB 150905 (Alliance): Rituximab Broadens the Antilymphoma Response by Activating Unlicensed NK Cells

(2014) J. Du et al.   Cancer Immunology Research

Protein corona significantly reduces active targeting yield

(2013) Vahid Mirshafiee et al.   CHEMICAL COMMUNICATIONS

Targeting Uptake Receptors on Human Plasmacytoid Dendritic Cells Triggers Antigen Cross-Presentation and Robust Type I IFN Secretion

(2013) J. Tel et al.   JOURNAL OF IMMUNOLOGY

Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface

(2013) Anna Salvati et al.   Nature Nanotechnology

Caveolae as plasma membrane sensors, protectors and organizers

(2013) Robert G. Parton et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Nanoparticle vaccines

(2013) Liang Zhao et al.   VACCINE

Targeting Dendritic Cells: The Role of Specific Receptors in the Internalization of Polymer Capsules

(2013) Justine D. Mintern et al.   Advanced Healthcare Materials

Promoter Targeting shRNA Suppresses HIV-1 Infection In vivo Through Transcriptional Gene Silencing

(2013) Kazuo Suzuki et al.   Molecular Therapy-Nucleic Acids

Constitutive Formation of Caveolae in a Bacterium

(2012) Piers J. Walser et al.   CELL

Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy

(2012) N. M. Archin et al.   NATURE

Tumor Immunotherapy Directed at PD-1

(2012) Antoni Ribas   NEW ENGLAND JOURNAL OF MEDICINE

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

(2012) Suzanne L. Topalian et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Evolution of the Protein Corona around Nanoparticles: A Test Study

(2011) Martin Lundqvist et al.   ACS Nano

Cancer immunotherapy comes of age

(2011) Ira Mellman et al.   NATURE

Transcriptional gene silencing of HIV-1 through promoter targeted RNA is highly specific

(2011) Kazuo Suzuki et al.   RNA Biology

Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice

(2010) Rupal Ramakrishnan et al.   JOURNAL OF CLINICAL INVESTIGATION

Uptake and Intracellular Fate of Surface-Modified Gold Nanoparticles

(2008) Paola Nativo et al.   ACS Nano

Binding, Internalization, and Antigen Presentation of Vaccine-Loaded Nanoengineered Capsules in Blood

(2008) Robert De Rose et al.   ADVANCED MATERIALS

Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection

(2008) B. F. Keele et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA